JGO Weekly Summary (August 20, 2024)

JGO Weekly Summary (August 20, 2024)

In this episode of the JGO Podcast, we explore two Editor's Choice studies focused on ovarian cancer. First, we delve into the work of Nozaki and colleagues, who investigate the role of specific biomarkers in predicting patient responses to PARP inhibitors. Their findings challenge the conventional reliance on genomic instability scores alone and offer new insights into personalized treatment strategies. Next, we discuss the study by Yuan and colleagues, which examines how a history of breast cancer affects the response to PARP inhibitors in ovarian cancer patients with BRCA1/2 mutations. Tune in to discover how these groundbreaking studies could shape the future of ovarian cancer treatment.


Article #1: Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer (https://doi.org/10.3802/jgo.2024.35.e55)

Article #2: PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer (https://doi.org/10.3802/jgo.2024.35.e51)

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(37)

JGO Weekly Summary (July 6, 2025)

JGO Weekly Summary (July 6, 2025)

This episode summarizes a cross-sectional study from Central China on HPV genotype distribution and infection risk factors. Ye Chen and colleagues found that HPV52, 16, and 58 were most common, with i...

6 Juli 20254min

JGO Weekly Summary (May 11, 2025)

JGO Weekly Summary (May 11, 2025)

In this episode of the JGO Podcast, we explore a recent study from Peking Union Medical College Hospital examining the role of adjuvant surgery in patients with high-risk chemorefractory or relapsed g...

11 Maj 20254min

JGO Weekly Summary (April 29, 2025)

JGO Weekly Summary (April 29, 2025)

This episode features an in-depth discussion of the Asian cohort analysis from the AtTEnd/ENGOT-EN7 phase III trial, which evaluated atezolizumab in combination with carboplatin and paclitaxel for adv...

1 Maj 20255min

JGO Weekly Summary (April 22, 2025)

JGO Weekly Summary (April 22, 2025)

In this episode, we review findings from the Japan subset of the DUO-E phase III trial, led by Shin Nishio and colleagues, which evaluated durvalumab with or without olaparib following chemotherapy in...

22 Apr 20254min

JGO Weekly Summary (April 10, 2025)

JGO Weekly Summary (April 10, 2025)

In this episode, we discuss the final analysis of the KEYNOTE-826 subgroup study led by Dr. Yong-Man Kim, evaluating pembrolizumab plus chemotherapy with or without bevacizumab in East Asian patients ...

10 Apr 20255min

JGO Weekly Summary (March 25, 2025)

JGO Weekly Summary (March 25, 2025)

In this episode of the Journal of Gynecologic Oncology podcast, we review a recent meta-analysis by Tianyu Zhang and colleagues titled "Role of Adjuvant Chemotherapy in Stage IC Ovarian Granulosa Cell...

26 Mars 20255min

JGO Weekly Summary (March 18, 2025)

JGO Weekly Summary (March 18, 2025)

In this episode of the Journal of Gynecologic Oncology podcast, we discuss a study by Baldwin and colleagues titled Evaluation of the Role of Liver Metastasectomy in the Treatment of Stage IV Endometr...

19 Mars 20254min

JGO Weekly Summary (March 11, 2025)

JGO Weekly Summary (March 11, 2025)

This episode explores a recent study on the increased risk of cardiovascular disease among adolescent and young adult survivors of cervical cancer. Using data from the Korean National Health Insurance...

11 Mars 20255min

Populärt inom Hälsa

somna-med-henrik
rss-jossan-nina
rss-bara-en-till-om-beroende-medberoende
bullfika
inga-beiga-morsor
rss-vuxna-pa-latsas
not-fanny-anymore
rss-viktmedicinpodden
angestpodden
sexnoveller-deluxe
johannes-hansen-podcast
rss-hos-psykologen
sa-in-i-sjalen
sova-med-dan-horning
rss-basta-livet
tyngre-traningssnack
halsoveckan-by-tyngre
brottarbroder
rss-angra-inget-3
rss-angra-inget-2